Considering that PUMA is a p53 downstream target, we selected several ovarian cancer cell lines as cell models to investigate the effects of Ad-PUMA on ovarian cancer cell proliferation according to our previous report [12]. The gene discussed is TP53; the disease is ovarian carcinoma.